Investors are pouring money into fusion at record speed, but which technologies, and which companies, will still be standing when the first commercial plant switches on? In this episode, finance industry specialist Stuart Allen breaks down the economics behind the plasma: how valuations are set, where supply-chain bottlenecks hide, and why the entire fusion ecosystem is poised for rapid growth.

About the guest

Stuart Allen is the co-founder and CEO of FusionX Group, which seeks to facilitate the efficient allocation of capital to fusion and the fusion supply chain. Through their news and data platform, FusionX informs the full spectrum of fusion market participants – fusion companies, supply chain, investors, advisers, and public-sector allies. With their series of FusionXInvest meetings, they connect fusion innovators, investors and partners with opportunity in fusion energy, propulsion, and spin-off applications including medical isotopes, remote imaging, and applied superconductivity.